Nucleai
Avi Veidman has a diverse work experience spanning over several years. Avi began their career in 1998 in technological leadership roles in the IDF Tech Unit within the Military Intelligence Corps. In 2017, they founded Inception Phase and was an entrepreneur there for four months. Later that year, they joined Nucleai as the CEO. At Nucleai, they developed and led the leading Spatial Biology Software Platform, which is used by more than 15 pharma and biotech companies for target discovery in drug R&D and clinical treatment decisions. Currently, Avi Veidman is a network member at 8400 The Health Network, starting in 2022.
Avi Veidman obtained a Bachelor of Science (BSc) degree in Geo-Information from Technion - Israel Institute of Technology, where they studied from 1993 to 1997. Following this, they pursued a Master's degree in Geo-Information from the same institute, completing it between 1998 and 2001.
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.